| Market Cap | ₹73Cr |
| ROE | 2.12% |
| P/E Ratio(TTM) | 2.68 |
| EPS(TTM) | 0.22 |
| P/B Ratio | 0.71 |
| Dividend Yield | 0.00% |
| Industry P/E | 41.00 |
| Book Value | 0.83 |
| Debt to Equity | 1.20 |
| Face Value | 1 |
| Parent Organisation | Welcure Drugs & Pharmaceuticals Limited |
| Managing Director | Shri. Sudhir Chandra |
| BSE Symbol | 524661 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 91.44 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.79 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.00 | ||
| Wockhardt | NA (0.00%) | -142.48 |